Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Kangji Medical Holdings Limited ( (HK:9997) ) is now available.
Kangji Medical Holdings Limited has announced a court-directed meeting for its independent shareholders to consider and potentially approve a scheme of arrangement. This meeting, scheduled for November 10, 2025, in Hong Kong, is a significant step in the company’s strategic planning, potentially impacting its operational structure and shareholder relations.
The most recent analyst rating on (HK:9997) stock is a Buy with a HK$10.00 price target. To see the full list of analyst forecasts on Kangji Medical Holdings Limited stock, see the HK:9997 Stock Forecast page.
More about Kangji Medical Holdings Limited
Kangji Medical Holdings Limited operates in the medical industry, focusing on the development and manufacturing of minimally invasive surgical instruments and accessories. The company primarily serves healthcare providers and aims to enhance surgical outcomes through innovative medical solutions.
YTD Price Performance: 46.72%
Average Trading Volume: 5,401,397
Technical Sentiment Signal: Buy
Current Market Cap: HK$10.5B
Learn more about 9997 stock on TipRanks’ Stock Analysis page.